cell-therapy

Documents about cell-therapy

• Abiraterone Acetate Affects Gene Expression Profile in a Human Male Neuronal Cell Line: Potential Mechanism for Cognitive Deficits with Prostate Cancer Therapy.#409241NCBI PubMed Central
• The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM#642354Europe PMC
• A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma#668820ClinicalTrials.gov
• Allogenic transplantation therapy of iPS cell-derived dopamine progenitors for Parkinson's disease -Current status of the Kyoto Trial and future perspectives-#785329Kyoto University Research Information Repository
• Metabolite Profiling and Network Pharmacology of Persimmon Vinegar (Diospyros kaki) Compounds, with in silico Validation for Non-Small Cell Lung Cancer Therapy.#796612NCBI PubMed Central
• Treatment of Complex Anal Fistulas Using Centrifuged Adipose Tissue Containing Progenitor Cells#830750ClinicalTrials.gov
• CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma#843987ClinicalTrials.gov
• Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)#846947ClinicalTrials.gov
• Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)#853851ClinicalTrials.gov
• Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial#807323ClinicalTrials.gov
• Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery#833063ClinicalTrials.gov
• Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma#841499ClinicalTrials.gov
• An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer#864054ClinicalTrials.gov
• Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN#861618ClinicalTrials.gov
• Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy#826190ClinicalTrials.gov
• Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors#801963ClinicalTrials.gov
• A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer#804906ClinicalTrials.gov
• A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy#834767ClinicalTrials.gov
• An Open Label, Single Arm, Multicenter Phase II Study of BYL719 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Who Failed to Respond to Platinum-based Therapy.#837232ClinicalTrials.gov
• SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)#850530ClinicalTrials.gov
• Cost-effectiveness analysis of tepotinib vs capmatinib as subsequent therapy in MET exon 14-mutated non-small-cell lung cancer#4488Europe PMC
• Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy#67866ClinicalTrials.gov
• Second primary cancers following hematologic malignancies: Epidemiology, pathobiology and clinical management#120200Europe PMC
• In-hospital and short-term outcomes in patients with atrial fibrillation undergoing chimeric antigen receptor-T cell therapy.#123385PubMed
• Dual-Peptide Nanoplatform: Mesoporous Silica Nanoparticles Functionalized With a Cell-Penetrating Peptide and Loaded With Rationally Designed Antimicrobial Peptides for Tuberculosis Therapy.#266908NCBI PubMed Central
• CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH#343840ClinicalTrials.gov
• Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma#426631ClinicalTrials.gov
• Multimodal profiling for prediction of primary resistance to anti-PD-(L)1 therapy in advanced non-small-cell lung cancer: the prospective PIONeeR biomarkers study#429584bioRxiv / medRxiv
• Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors#460088ClinicalTrials.gov
• Therapeutic Potential of EWSR1-FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma#646694Repisalud
• A proposal of good manufacturing practices (GMP) laboratory for CAR T-cell therapy in Latin America and the Caribbean: challenges and opportunities.#653376NCBI PubMed Central
• Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome#803063ClinicalTrials.gov
• CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy#813686ClinicalTrials.gov
• A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC#825150ClinicalTrials.gov
• Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer#826812ClinicalTrials.gov
• Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease#843231ClinicalTrials.gov
• Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer#846233ClinicalTrials.gov
• CHiR Therapy for Elderly DLBCL Intolerant to Chemo#850023ClinicalTrials.gov
• Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy#850732ClinicalTrials.gov
• Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)#146457ClinicalTrials.gov
• Impact of first-line immunotherapy on survival and intracranial outcomes from a real-world cohort of patients with non-small cell lung cancer with brain metastases at diagnosis.#676991HAL (France)
• Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer#807992ClinicalTrials.gov
• Safety Study of MultiGeneAngio in Patients With Chronic Critical Limb Ischemia#813078ClinicalTrials.gov
• Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.#862642ClinicalTrials.gov
• Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer#429744ClinicalTrials.gov
• Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity#841915ClinicalTrials.gov
• Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer#67876ClinicalTrials.gov
• Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer#158222ClinicalTrials.gov
• CFTR modulator response in nasal organoids derived from people with cystic fibrosis#288364IRIS
• The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy#332762ClinicalTrials.gov